Table 1 Baseline characteristics of patients with and without anxiety disorders
Demographic data | Patients with anxiety disorders | Patients without anxiety disorders | P value | ||
|---|---|---|---|---|---|
n = 7735 | n = 7735 | ||||
n | % | n | % | ||
Age (years)a | 43 (33–55) | 43 (33–55) | |||
≥ 60 | 1417 | 18.3 | 1417 | 18.3 | >.999 |
< 60 | 6318 | 81.7 | 6318 | 81.7 | |
Sex | |||||
Male | 3225 | 41.7 | 3225 | 41.7 | >.999 |
Female | 4510 | 58.3 | 4510 | 58.3 | |
Comorbidities | |||||
Hypertension | 1932 | 25.0 | 966 | 12.5 | <.001 |
Diabetes mellitus | 358 | 4.6 | 230 | 3.0 | <.001 |
Chronic liver diseases | 2314 | 29.9 | 857 | 11.1 | <.001 |
Autoimmune diseases | 679 | 8.8 | 311 | 4.0 | <.001 |
Congestive heart failure | 234 | 3.0 | 101 | 1.3 | <.001 |
Hyperlipidemia | 1411 | 18.0 | 620 | 8.0 | <.001 |
Nephropathy | 696 | 9.0 | 274 | 3.5 | <.001 |
Cerebrovascular disease | 792 | 10.2 | 279 | 3.6 | <.001 |
COPD | 1682 | 21.7 | 779 | 10.1 | <.001 |
Follow-up yearsa | 11.24 (9.97–12.61) | 11.27 (10.00–12.64) | .012 | ||